Development of monoclonal antibody imaging of metastatic prostatic carcinoma

Frederick J Meyers, S. J. Denardo, D. Macey, Ralph W deVere White, M. Unger

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Indium-111-labeled monoclonal antibody directed against prostate-specific antigen was injected into ten patients with known prostatic carcinoma, nine with metastatic disease. The monoclonal antibody scan was compared to the standard technetium bone scan, and both were correlated to clinical status and to 2-year follow-up. The ratio of target-to-nontarget activity and pharmacokinetics of the radiolabeled antibody approach may be used for staging and may be developed as a therapeutic adjuvant.

Original languageEnglish (US)
Pages (from-to)209-220
Number of pages12
JournalProstate
Volume14
Issue number3
StatePublished - 1989

Fingerprint

Monoclonal Antibodies
Carcinoma
Indium
Technetium
Prostate-Specific Antigen
Pharmacokinetics
Bone and Bones
Antibodies
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Development of monoclonal antibody imaging of metastatic prostatic carcinoma. / Meyers, Frederick J; Denardo, S. J.; Macey, D.; deVere White, Ralph W; Unger, M.

In: Prostate, Vol. 14, No. 3, 1989, p. 209-220.

Research output: Contribution to journalArticle

Meyers, FJ, Denardo, SJ, Macey, D, deVere White, RW & Unger, M 1989, 'Development of monoclonal antibody imaging of metastatic prostatic carcinoma', Prostate, vol. 14, no. 3, pp. 209-220.
Meyers, Frederick J ; Denardo, S. J. ; Macey, D. ; deVere White, Ralph W ; Unger, M. / Development of monoclonal antibody imaging of metastatic prostatic carcinoma. In: Prostate. 1989 ; Vol. 14, No. 3. pp. 209-220.
@article{08b2c847e846464d955d475d0fde454b,
title = "Development of monoclonal antibody imaging of metastatic prostatic carcinoma",
abstract = "Indium-111-labeled monoclonal antibody directed against prostate-specific antigen was injected into ten patients with known prostatic carcinoma, nine with metastatic disease. The monoclonal antibody scan was compared to the standard technetium bone scan, and both were correlated to clinical status and to 2-year follow-up. The ratio of target-to-nontarget activity and pharmacokinetics of the radiolabeled antibody approach may be used for staging and may be developed as a therapeutic adjuvant.",
author = "Meyers, {Frederick J} and Denardo, {S. J.} and D. Macey and {deVere White}, {Ralph W} and M. Unger",
year = "1989",
language = "English (US)",
volume = "14",
pages = "209--220",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Development of monoclonal antibody imaging of metastatic prostatic carcinoma

AU - Meyers, Frederick J

AU - Denardo, S. J.

AU - Macey, D.

AU - deVere White, Ralph W

AU - Unger, M.

PY - 1989

Y1 - 1989

N2 - Indium-111-labeled monoclonal antibody directed against prostate-specific antigen was injected into ten patients with known prostatic carcinoma, nine with metastatic disease. The monoclonal antibody scan was compared to the standard technetium bone scan, and both were correlated to clinical status and to 2-year follow-up. The ratio of target-to-nontarget activity and pharmacokinetics of the radiolabeled antibody approach may be used for staging and may be developed as a therapeutic adjuvant.

AB - Indium-111-labeled monoclonal antibody directed against prostate-specific antigen was injected into ten patients with known prostatic carcinoma, nine with metastatic disease. The monoclonal antibody scan was compared to the standard technetium bone scan, and both were correlated to clinical status and to 2-year follow-up. The ratio of target-to-nontarget activity and pharmacokinetics of the radiolabeled antibody approach may be used for staging and may be developed as a therapeutic adjuvant.

UR - http://www.scopus.com/inward/record.url?scp=0024390192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024390192&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 209

EP - 220

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 3

ER -